A new plant-based gel designed to quickly stop severe bleeding has received FDA approval, marking a significant advancement in emergency medical care.
Stop Bleeding in Seconds
The gel, which comes in a pre-filled syringe, is easy to apply and requires no preparation, making it an essential tool for emergency medical technicians (EMTs) and healthcare providers.
Unlike many current hemostatic agents and bandages, which can be difficult to apply and are not always effective in all types of bleeding, this innovative gel is designed to control and stop life-threatening hemorrhages in just seconds.
This is crucial in emergency situations where every second counts, particularly in trauma care.
Release by end of 2024
The gel, derived from algae, doesn't require manual pressure on the wound to form a blood clot, a significant improvement over existing treatments that can take over five minutes to work and require continuous pressure.
The FDA’s approval is based on preclinical data comparing the gel to standard care products, highlighting its superior speed and effectiveness.
Scheduled for release by the end of 2024, the gel is expected to meet the needs of the U.S. military, government health agencies, emergency medical services (EMS), and other healthcare professionals who frequently encounter traumatic injuries.
With hemorrhage-related deaths occurring every three minutes and 40% of these deaths due to major bleeding, this gel could save countless lives by providing a faster, more efficient way to control bleeding.
The gel's potential impact is enormous, especially considering that 91% of battlefield deaths are linked to preventable bleeding.
